540726 TTFL

Trident Texofab Share Price

₹161.90 +3.15 (1.98%)

23 Dec, 2024 03:53

SIP TrendupStart SIP in TTFL

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 51.1%
  • Over 3 Month + 245.79%
  • Over 6 Month + 240.84%
  • Over 1 Year + 155.56%
SIP Lightning

Smart Investing Starts Here Start SIP with Trident Texofab for Steady Growth!

Invest Now

Trident Texofab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Trident Texofab Financials

Trident Texofab Technicals

EMA & SMA

Current Price
₹161.90
+ 3.15 (1.98%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹137.73
  • 50 Day
  • ₹113.42
  • 100 Day
  • ₹91.20
  • 200 Day
  • ₹75.36

Resistance and Support

161.9 Pivot Speed
  • R3 161.90
  • R2 161.90
  • R1 161.90
  • S1 161.90
  • S2 161.90
  • S3 161.90

What's your outlook on Trident Texofab?

You can only vote for once

Trident Texofab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Others
2024-10-12 Quarterly Results
2024-07-18 Quarterly Results (Revised) issue in the ratio of 14:10 of Rs. 10/-
2024-05-25 Audited Results (Revised) issue in the ratio of 14:10 of Rs. 10/-
2024-02-14 Quarterly Results

Trident Texofab F&O

Trident Texofab Shareholding Pattern

No data available.

About Trident Texofab

  • NSE Symbol
  • TTFL
  • BSE Symbol
  • 540726
  • ISIN
  • INE071Y01013

Similar Stocks to Trident Texofab

Trident Texofab FAQs

Trident Texofab share price is ₹161 As on 23 December, 2024 | 03:39

The Market Cap of Trident Texofab is ₹163 Cr As on 23 December, 2024 | 03:39

The P/E ratio of Trident Texofab is 75.7 As on 23 December, 2024 | 03:39

The PB ratio of Trident Texofab is 10 As on 23 December, 2024 | 03:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23